Additional dopamine reuptake inhibition attenuates vigilance impairment induced by serotonin reuptake inhibition in man. [electronic resource]
Producer: 20030407Description: 207-14 p. digitalISSN:- 0269-8811
- Adult
- Attention -- drug effects
- Cross-Over Studies
- Depressive Disorder -- drug therapy
- Dopamine Uptake Inhibitors -- adverse effects
- Double-Blind Method
- Female
- Humans
- Male
- Middle Aged
- Neuropsychological Tests
- Paroxetine -- adverse effects
- Selective Serotonin Reuptake Inhibitors -- adverse effects
- Sertraline -- adverse effects
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.